A Systematic Review of Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Engaging an Old Problem With New Solutions.
Zachery HalfordCarli CoalterVanessa GreshamTabitha BrownPublished in: The Annals of pharmacotherapy (2021)
Blinatumomab provides a paradigm-shifting treatment option; however, many questions surrounding optimal patient selection, sequencing, and cost-effectiveness remain.